Biodefense
Biodefense refers to measures to restore
Biodefense applies to two distinct target populations: civilian non-combatant and military combatant (troops in the field). Protection of water supplies and food supplies are often a critical part of biodefense.
Military
Troops in the field
The
This section needs expansion. You can help by adding to it. (April 2011) |
Civilian
Role of public health and disease surveillance
It's extremely important to note that all of the classical and modern biological weapons organisms are animal diseases, the only exception being smallpox. Thus, in any use of biological weapons, it is highly likely that animals will become ill either simultaneously with, or perhaps earlier than humans.
Indeed, in the largest biological weapons accident known–the anthrax outbreak in Sverdlovsk (now Yekaterinburg) in the Soviet Union in 1979, sheep became ill with anthrax as far as 200 kilometers from the release point of the organism from a military facility in the southeastern portion of the city (known as Compound 19 and still off limits to visitors today, see Sverdlovsk anthrax leak).
Thus, a robust surveillance system involving human clinicians and veterinarians may identify a bioweapons attack early in the course of an epidemic, permitting the prophylaxis of disease in the vast majority of people (and/or animals) exposed but not yet ill.
For example, in the case of anthrax, it is likely that by 24–36 hours after an attack, some small percentage of individuals (those with compromised immune system or who had received a large dose of the organism due to proximity to the release point) will become ill with classical symptoms and signs (including a virtually unique
Identification of bioweapons
The goal of biodefense is to integrate the sustained efforts of the national and
The traditional approach toward protecting agriculture, food, and water: focusing on the natural or unintentional introduction of a disease is being strengthened by focused efforts to address current and anticipated future biological weapons threats that may be deliberate, multiple, and repetitive.
The growing threat of biowarfare agents and bioterrorism has led to the development of specific field tools that perform on-the-spot analysis and identification of encountered suspect materials. One such technology, being developed by researchers from the Lawrence Livermore National Laboratory (LLNL), employs a "sandwich immunoassay", in which fluorescent dye-labeled antibodies aimed at specific pathogens are attached to silver and gold nanowires.[1]
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) also participates in the identification and prevention of biowarfare and first released a strategy for biodefense in 2002, periodically releasing updates as new pathogens are becoming topics of discussion. Within this list of strategies, responses for specific infectious agents are provided, along with the classification of these agents. NIAID provides countermeasures after the U.S. Department of Homeland Security details which pathogens hold the most threat.
Planning and response
Planning may involve the training human resources specialist and development of biological identification systems. Until recently in the United States, most biological defense strategies have been geared to protecting soldiers on the battlefield rather than ordinary people in cities. Financial cutbacks have limited the tracking of disease outbreaks. Some outbreaks, such as food poisoning due to E. coli or Salmonella, could be of either natural or deliberate origin.
Human Resource Training Programs
To date, several endangered countries have designed various training programs at their universities to train specialized personnel to deal with biological threats(for example: George Mason University Biodefense PhD program (USA)[2] or Biodefense Strategic Studies PhD program designated by Dr Reza Aghanouri(Iran)[3]). These programs are designed to prepare students and officers to serve as scholars and professionals in the fields of biodefense and biosecurity. These programs integrates knowledge of natural and man-made biological threats with the skills to develop and analyze policies and strategies for enhancing biosecurity. Other areas of biodefense, including nonproliferation, intelligence and threat assessment, and medical and public health preparedness are integral parts of these programs.
Preparedness
Biological agents are relatively easy to obtain by terrorists and are becoming more threatening in the U.S., and laboratories are working on advanced detection systems to provide early warning, identify
Early detection and rapid response to bioterrorism depend on close cooperation between public health authorities and law enforcement; however, such cooperation is currently lacking. National detection assets and vaccine stockpiles are not useful if local and state officials do not have access to them.[4]
United States strategy
In September 2018, President Trump and his administration unveiled a new comprehensive plan, the National Biodefense Strategy, for how the government will oversee bioterrorism defense. Currently, there are 15 federal departments and agencies and 16 branches of intelligence community that work against biological threats. The work of these groups often overlaps. So one of the goals of the National Biodefense Strategy to streamline the efforts of these agencies to prevent overlapping responsibilities.[5]
The group of people in charge of overseeing biodefense policy will be the
The U.S. government had a comprehensive defense strategy against bioterror attacks in 2004, when then-President George W. Bush signed a Homeland Security Presidential Directive 10.[6] The directive laid out the country's 21st Century biodefense system and assigned various tasks to federal agencies that would prevent, protect and mitigate biological attacks against our homeland and global interests. Since that time, however, the federal government has not had a comprehensive biodefense strategy. Daniel Gerstein, a senior policy researcher at the RAND Corporation and former acting undersecretary and deputy undersecretary of the Department of Homeland Security's Science and Technology Directorate said, "...we haven't had any major bioterror attacks [since the anthrax attacks of 2001] so this sort of leaves the public's consciousness and that's when complacency sets in."[7]
Biosurveillance
In 1999, the
On February 5, 2002,
The principles and practices of biosurveillance, a new interdisciplinary science, were defined and described in the Handbook of Biosurveillance, edited by Michael Wagner, Andrew Moore and Ron Aryel, and published in 2006. Biosurveillance is the science of real-time disease outbreak detection. Its principles apply to both natural and man-made epidemics (bioterrorism).
Data which potentially could assist in early detection of a bioterrorism event include many categories of information. Health-related data such as that from hospital computer systems, clinical laboratories, electronic
In Europe, disease surveillance is beginning to be organized on the continent-wide scale needed to track a biological emergency. The system not only monitors infected persons, but attempts to discern the origin of the outbreak.
Researchers are experimenting with devices to detect the existence of a threat:
- Tiny electronic chips that would contain living nerve cells to warn of the presence of bacterial toxins (identification of broad range toxins)
- Fiber-optic tubes lined with antibodiescoupled to light-emitting molecules (identification of specific pathogens, such as anthrax, botulinum, ricin)
New research shows that ultraviolet
The United States Department of Defense conducts global biosurveillance through several programs, including the Global Emerging Infections Surveillance and Response System.[12]
Response to bioterrorism incident or threat
Government agencies which would be called on to respond to a bioterrorism incident would include law enforcement, hazardous materials/decontamination units and emergency medical units. The US military has specialized units, which can respond to a bioterrorism event; among them are the
Biodefense market
In 2015, global biodefense market was estimated at $9.8 billion. Experts correlated the large marketplace to an increase in government attention and support as a result of rising bioterrorism threats worldwide. Government's heightened interest is anticipated expand the industry into the foreseeable future. According to Medgadget.com, "Many government legislations like Project Bioshield offers nations with counter measures against chemical, radiological, nuclear and biological attack."[13]
Project Bioshield offers accessible biological countermeasures targeting various strains of smallpox and anthrax. "Main goal of the project is creating funding authority to build next generation counter measures, make innovative research & development programs and create a body like FDA (Food & Drug Administration) that can effectively use treatments in case of emergencies."[13] Increased funding, in addition to public health organizations' elevated consideration in biodefense technology investments, could trigger growth in the global biodefense market.[13]
The global biodefense market is divided into geographical locations such as APAC, Latin America, Europe, MEA, and North America. The biodefense industry in North America lead the global industry by a large margin, making it the highest regional revenue share for 2015, contributing approximately $8.91 billion of revenue this year, due to immense funding and government reinforcements. The biodefense market in Europe is predicted to register a CAGR of 11.41% by the forecast timeline. The United Kingdom's Ministry of Defense granted $75.67 million designated for defense & civilian research, making it the highest regional industry share for 2012.[13]
In 2016, Global Market Insights released a report covering the new trends in the biodefense market backed by detailed, scientific data. Industry leaders in biodefense market include the following corporations: Emergent Biosolutions, SIGA Technologies, Ichor Medical Systems Incorporation, PharmaAthene, Cleveland BioLabs Incorporation, Achaogen (bankrupt in 2019[14]), Alnylam Pharmaceuticals, Avertis,[15] Xoma Corporation, Dynavax Technologies Incorporation, Elusys Therapeutics, DynPort Vaccine Company LLC, Bavarian Nordic and Nanotherapeutics Incorporation.[13]
Legislation
During the 115th Congress in July 2018, four Members of Congress, both Republican and Democrat (Anna Eshoo, Susan Brooks, Frank Palone and Greg Walden) introduced biodefense legislation called the Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPA) (H.R. 6378). The bill strengthens the federal government's preparedness to deal with a wide range of public health emergencies, whether created through an act of bioterrorism or occurring through a natural disaster. The bill reauthorizes funding to improve bioterrorism and other public health emergency preparedness and response activities such as the Hospital Preparedness Program, the Public Health Emergency Preparedness Cooperative Agreement, Project BioShield, and BARDA for the advanced research and development of medical countermeasures (MCMs).[16]
H.R. 6378 has 24 cosponsors from both political parties. On September 25, 2018, the House of Representatives passed the bill.[17]
See also
- Fluctuation-enhanced sensing of biological and chemical agents
- National Biodefense Analysis and Countermeasures Center (NBACC)
- Sensing of phage-triggered ion cascades
- United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
- United States biological defense program
References
Citations
- ^ "Physorg.com, "Encoded Metallic Nanowires Reveal Bioweapons", 12:50 EST, August 10, 2006".
- ^ "Latest News".
- ^ "If we backed down on nuclear energy, they would come to nanotechnology tomorrow" (in Persian). January 14, 2008.
- ^ Bernett, Brian C. (December 2006), US Biodefense and Homeland Security: Toward Detection and Attribution (PDF), Monterey, California, United States: Naval Postgraduate School, p. 21, archived from the original (PDF) on February 29, 2008, retrieved May 24, 2009
- ^ a b Cohen, John (September 19, 2018). "Trump's biodefense plan aims to improve coordination across agencies". Science | AAAS. Retrieved September 28, 2018.
- ^ Homeland Security Presidential Directive - 10 (PDF). U.S. Government Printing Office. 2004. pp. 57–65.
- ^ Rozens, Tracy (September 2, 2016). "RAND's Gerstein: U.S. needs biodefense strategy to protect against terror threats". Homeland Preparedness News. Retrieved December 2, 2016.
- ^ a b Wagner, Michael M.; Espino, Jeremy; et al. (2004), "The role of clinical information systems in public health surveillance", Healthcare Information Management Systems (3 ed.), New York: Springer-Verlag, pp. 513–539
- ^ a b Wagner, Michael M.; Aryel, Ron; et al. (November 28, 2001), Availability and Comparative Value of Data Elements Required for an Effective Bioterrorism Detection System (PDF), Real-time Outbreak and Disease Surveillance Laboratory, archived from the original (PDF) on March 3, 2011, retrieved May 22, 2009
- ^ Togyer, Jason (June 2002), Pitt Magazine: Airborne Defense, University of Pittsburgh, archived from the original on June 16, 2010, retrieved May 22, 2009
- ^ Avalanche Photodiodes Target Bioterrorism Agents Newswise, Retrieved on June 25, 2008.
- ^ Pellerin, Cheryl. "Global Nature of Terrorism Drives Biosurveillance." Archived January 12, 2013, at the Wayback Machine American Forces Press Service, 27 October 2011.
- ^ a b c d e "Biodefense Market size worth $17bn by 2024". Medgadget.com. September 26, 2016. Archived from the original on October 5, 2016. Retrieved October 3, 2016.
- ^ Jacobs, Andrew (December 25, 2019). "Crisis Looms in Antibiotics as Drug Makers Go Bankrupt". The New York Times. Retrieved November 23, 2022.
- ^ "Next Generation Biodefense". Surturian.com. February 20, 2021. Retrieved February 20, 2021.
- ^ "Eshoo, Brooks Introduce Legislation to Combat Biodefense Threats". Retrieved November 30, 2018.
- ^ Susan, Brooks (September 26, 2018). "Actions - H.R.6378 - 115th Congress (2017-2018): Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018". www.congress.gov. Retrieved November 30, 2018.
Other sources
- Department of Defense (2001). Report on Biological Warfare Defense Vaccine Research & Development Programs. Retrieved 2005-02-25.
- Institute of Medicine and National Research Council of the National Academies (2004). Giving Full Measure to Countermeasures: Addressing Problems in the DoD Program to Develop Medical Countermeasures Against Biological Warfare Agents. National Academy Press (Washington, D.C.). ISBN 0-309-09153-5(paperback).
External links
- BiodefenseEducation.org - A biodefense digital library and learning collaboratory
- NIAID Biodefense Research
- The Biodefense Field